Flu Treatment Market

Industry Overview

From USD 0.98 billion in 2023, the Global Flu Treatment Market is predicted to grow to USD 1.8 billion by 2030, registering a CAGR of 5.3% during the forecast period (2025–2030). The growth of this market is attributed towards due to the rapid explosion of COVID-19 disease globally that is causing deaths massively across the globe, increasing technological upgradation and increasing research funding availed by government authorities towards the treatment of such epidemic for flu is further bolstering the growth of global flu treatment market.

Flu that is also termed as influenza is considered to be a common viral infection. The common symptoms of flu are muscle aches, fever, headaches, chills, cough, runny nose, and fever. It is observed that in the case of flu respiratory tract is affected. Furthermore, it is observed that in case of COVID-19, causes severe damage to the lungs and respiratory tracts and the development of drugs under the pipeline could further accelerate the growth of the global flu treatment market. 

Market Segmentation

Insight by Type

On the basis of type, the global flu treatment market is categorized into type A, type B, and type C. Amongst these segments, type A segment is observed to generate significant revenue gains as the global epidemic that is COVID-19 comes in type A. Type A mutations are considered to be major flu epidemics that occur after every few years.

Insight by Route of Administration

On the basis of the route of administration, the global flu treatment market is categorized into oral, parenteral, and others. Amongst these segments, the parenteral segment is expected to witness the highest CAGR during the forecast period as the epidemic is causing a lot of respiratory damage amongst the patients and is very dangerous in order to tackle the situation immediately the medicines are required to be injected in the intestine to gain a rapid result. 

Insight by Medication

Based on medication, the global flu treatment market is segmented into analgesics, antiviral drugs, antihistamines, and others. Of all medications, antiviral drugs are anticipated to generate the largest revenue by 2025 as and when the vaccine would be developed it would cause a rapid increase in demand, and due to coronavirus cases globally, antiviral drugs would be gaining massive demand.

Insight by End User

On the basis of end users, the global flu treatment market is segmented into hospitals, specialty clinics, and others. Amongst these segments, the hospital's segment is expected to witness the highest CAGR during the forecast period as the number of patients suffering from COVID-19 are under isolation wards in the hospitals or are being taken care of by hospital workers thus treated patients or anyone the global flu treatment market would grow at a massive rate.

Insight by Distribution Channel

On the basis of distribution channels, the global flu treatment market is classified into hospital pharmacies, retail pharmacies, and others. Amongst these segments, hospital pharmacy is expected to witness the highest CAGR during the forecast period as large numbers of patients across the globe are suffering from COVID-19 crisis that is further accentuating the global flu treatment market. 

Global Flu Treatment Market Report Coverage

Industry Dynamics

Growth Drivers

Increasing demand for medical needs at the time of the epidemic, an excessive number of coronavirus cases globally, and increasing funding and grants provided by government authorities towards research and innovation of the COVID-19 vaccine are the key factors that are driving the growth of the global flu treatment market.  COVID-19 came into notice in Dec 2023 in China and after that, the number of cases and count of COVID-19 patients are increasing massively globally. This virus infection has no treatment, and no vaccine to date, and the only way to come out of this epidemic is to prevent its occurrence.

According to a report by WHO in March 2020, the number of coronavirus patients exceeded 200000, and in almost after twelve days the number would exceed 100000. Furthermore, this would not provide assurance or time to make things back to normal or right on track as all human activities whether economic or social have been hampered by this virus. Moreover, in order to combat the situation WHO (World Health Organization) has urged all developed and developing countries to invent a drug or vaccine that could treat the disease as a result to which the global flu treatment market is anticipated to observe rapid growth. 

Increasing Global Incidence: The flu is a recurring seasonal illness that affects a significant portion of the population annually. The constant circulation of different strains of the influenza virus drives the demand for flu treatments, including vaccines and antiviral medications.

Government Immunization Programs: Many governments worldwide actively promote and implement flu vaccination programs, especially for high-risk groups such as young children, older adults, pregnant women, and individuals with underlying health conditions. These initiatives contribute to increased vaccine demand and subsequent market growth.

Advancements in Vaccine Technology: Continuous research and development efforts have led to advancements in vaccine technology. This includes the development of new vaccine formulations, improved production methods, and broader strain coverage. These advancements enhance the efficacy and effectiveness of flu vaccines, driving their adoption and market growth.

Growing Healthcare Expenditure: As healthcare expenditure increases globally, there is a greater focus on preventing and managing diseases like the flu. The willingness to spend on preventive measures, diagnosis, and treatment contributes to the growth of the flu treatment market.

Challenges

However, increasing challenges prevailing due to patent expiration of branded drugs, research and development, and the launch of generic versions to fight certain flu are a few factors expected to hamper the growth of the global flu treatment market.

Vaccine production involves a complex process that requires timely strain identification, production of seed viruses, and large-scale manufacturing. Delays or disruptions in any of these steps can impact the availability and distribution of flu vaccines, especially during periods of high demand. In some regions, limited healthcare infrastructure, particularly in rural or low-resource areas, can hinder access to flu treatments. Ensuring equitable access to vaccines, diagnostic tests, and antiviral medications is a challenge that needs to be addressed to effectively combat the flu.

Geographic Overview

Geographically, Europe was the largest revenue contributor in the global flu treatment market in 2019 & 2020, due to massive growth of COVID-19 in the region. According to a report published by European Union, approximately 1,563,857 cases of COVID-19 has been discovered in Europe in the first week of April and the total number of deaths registered in the region was 95,044. As a result of this, the demand for developing vaccines is our most important in order to reduce the death counts and those affected by the virus.

Countries such as Spain, Italy, Germany, France, and the U.K. registered the largest number of patients affected with COVID-19 as a result to which government has allocated significant funds to the innovation of vaccine that is expected to bolster the growth of the global flu treatment market.

Moreover, the flu treatment market in Asia-Pacific is expected to witness the highest CAGR during the forecast period owing to the outbreak of COVID-19 in countries such as India which has recently exploded in the country, and also in China where the origin of COVID-19 patients occurred. Although China is observing improvement in death rates due to COVID-19, the patients recovering completely from the flu are still in huge numbers that are required to be treated as soon as possible as this disease is very contagious and could lead to severe health hazards. 

Competitive Insight

Key players in the global flu treatment market are rapidly accentuating efforts such as investment in research and development, new product development, and strengthening company strategic decisions in order to make the world recover from the epidemic as soon as possible.

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.

AstraZeneca is a global, science-led biopharmaceutical business and its innovative medicines are used by millions of patients worldwide.

Some of the major players operating in the global flu treatment market are GlaxoSmithKline plc, AstraZeneca, Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Eli Lilly, and Company, Novartis AG, NATCO Pharma Limited, Merck & Co., F. Hoffmann-La Roche Ltd, Inc., Bayer AG, Mylan N.V., Pfizer Inc., and Sanofi.

Recent Developments by Key Players

AstraZeneca has opened a USD 1.5 billion manufacturing facility in Singapore to produce a category of cancer-killing drugs called antibody-drug conjugates (ADCs). The facility, which will be the drugmaker's first end-to-end ADC production site, that will be supported by the Singapore Economic Development Board.

Bristol Myers Squibb (BMS) has opened an innovation hub in Hyderabad, India, to expand its global drug development, digital capabilities and information technology. 

Primary Research

VynZ Research conducts extensive primary research to understand the market dynamics, validate market data and have key opinions from industry experts. The key profiles approached within the industry include, CEO, CFO, CTO, President, Vice President, Product Managers, Regional Heads, and Others. Also, end user surveys comprising of consumers are also conducted to understand consumer behavior.

The Flu Treatment Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

• By Type
  • Type A
  • Type B
  • Type C
• By Route of Administration
  • Oral
  • Parenteral
  • Others
• By Medication
  • Analgesics
  • Antiviral Drugs
  • Antihistamines
  • Others
• By End User
  • Hospitals
  • Specialty Clinics
  •  Others
• By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Flu Treatment Market by Region

• North America
  • By Type
  • By Route of Administration
  • By Medication
  • By End User
  • By Distribution Channel
  • By Country – U.S., Canada, and Mexico
• Europe
  • By Type
  • By Route of Administration
  • By Medication
  • By End User
  • By Distribution Channel
  • By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe
• Asia-Pacific (APAC)
  • By Type
  • By Route of Administration
  • By Medication
  • By End User
  • By Distribution Channel
  • By Country – China, Japan, India, Australia, Singapore, South Korea, Indonesia, and Rest of Asia-Pacific
• Rest of the World (RoW)
  • By Type
  • By Route of Administration
  • By Medication
  • By End User
  • By Distribution Channel
  • By Country – Brazil, Argentina, South Africa, Saudi Arabia, Iran, U.A.E., and Other Countries

Source: VynZ Research

Source: VynZ Research

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Type
                1.2.2.    By Route of Administration
                1.2.3.    By Medication
                1.2.4.    By End User
                1.2.5.    By Distribution Channel
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Research Methodology
                1.5.1.    Data Sources
                        1.5.1.1.    Primary Research
                        1.5.1.2.    Secondary Research
                1.5.2.    Methodology
                        1.5.2.1.    Data Exploration
                        1.5.2.2.    Forecast Parameters
                        1.5.2.3.    Data Validation
                        1.5.2.4.    Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis
                3.3.3.    Company Share Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2030

5.    Market Segmentation Estimate and Forecast

        5.1.    By Type
                5.1.1.    Type A
                        5.1.1.1.    Market Definition
                        5.1.1.2.    Market Estimation and Forecast to 2030
                5.1.2.    Type B
                        5.1.2.1.    Market Definition
                        5.1.2.2.    Market Estimation and Forecast to 2030
                5.1.3.    Type C
                        5.1.3.1.    Market Definition
                        5.1.3.2.    Market Estimation and Forecast to 2030
        5.2.    By Route of Administration
                5.2.1.    Oral
                        5.2.1.1.    Market Definition
                        5.2.1.2.    Market Estimation and Forecast to 2030
                5.2.2.    Parenteral 
                        5.2.2.1.    Market Definition
                        5.2.2.2.    Market Estimation and Forecast to 2030
                5.2.3.    Others
                        5.2.3.1.    Market Definition
                        5.2.3.2.    Market Estimation and Forecast to 2030
        5.3.    By Medication
                5.3.1.    Analgesics
                        5.3.1.1.    Market Definition
                        5.3.1.2.    Market Estimation and Forecast to 2030
                5.3.2.    Antiviral Drugs
                        5.3.2.1.    Market Definition
                        5.3.2.2.    Market Estimation and Forecast to 2030
                5.3.3.     Antihistamines 
                        5.3.3.1.    Market Definition
                        5.3.3.2.    Market Estimation and Forecast to 2030
                5.3.4.    Others
                        5.3.4.1.    Market Definition
                        5.3.4.2.    Market Estimation and Forecast to 2030
        5.4.    By End User
                5.4.1.    Hospitals
                        5.4.1.1.    Market Definition
                        5.4.1.2.    Market Estimation and Forecast to 2030
                5.4.2.    Specialty Clinics 
                        5.4.2.1.    Market Definition
                        5.4.2.2.    Market Estimation and Forecast to 2030
                5.4.3.    Others
                        5.4.3.1.    Market Definition
                        5.4.3.2.    Market Estimation and Forecast to 2030
        5.5.    By Distribution Channels
                5.5.1.    Hospital Pharmacy
                        5.5.1.1.    Market Definition
                        5.5.1.2.    Market Estimation and Forecast to 2030
                5.5.2.    Retail Pharmacy 
                        5.5.2.1.    Market Definition
                        5.5.2.2.    Market Estimation and Forecast to 2030
                5.5.3.    Others
                        5.5.3.1.    Market Definition
                        5.5.3.2.    Market Estimation and Forecast to 2030

6.    North America Market Estimate and Forecast

        6.1.    By Type
        6.2.    By Route of Administration
        6.3.    By Medication
        6.4.    By End User
        6.5.    By Distribution Channel
        6.6.    By Country
                6.6.1.    U.S. Market Estimate and Forecast
                6.6.2.    Canada Market Estimate and Forecast
                6.6.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Type
        7.2.    By Route of Administration
        7.3.    By Medication
        7.4.    By End User
        7.5.    By Distribution Channel
        7.6.    By Country
                7.6.1.    Germany Market Estimate and Forecast
                7.6.2.    France Market Estimate and Forecast
                7.6.3.    U.K. Market Estimate and Forecast
                7.6.4.    Italy Market Estimate and Forecast
                7.6.5.    Spain Market Estimate and Forecast
                7.6.6.    Russia Market Estimate and Forecast
                7.6.7.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Type
        8.2.    By Route of Administration
        8.3.    By Medication
        8.4.    By End User
        8.5.    By Distribution Channel
        8.6.    By Country 
                8.6.1.    China Market Estimate and Forecast
                8.6.2.    Japan Market Estimate and Forecast
                8.6.3.    India Market Estimate and Forecast
                8.6.4.    Australia Market Estimate and Forecast
                8.6.5.    Singapore Market Estimate and Forecast
                8.6.6.    South Korea Market Estimate and Forecast
                8.6.7.    Indonesia Market Estimate and Forecast
                8.6.8.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Type
        9.2.    By Route of Administration
        9.3.    By Medication
        9.4.    By End User
        9.5.    By Distribution Channel
        9.6.    By Country
                9.6.1.    Brazil Market Estimate and Forecast
                9.6.2.    Argentina Market Estimate and Forecast
                9.6.3.    Saudi Arabia Market Estimate and Forecast
                9.6.4.    South Africa Market Estimate and Forecast
                9.6.5.    Iran Market Estimate and Forecast
                9.6.6.    U.A.E. Market Estimate and Forecast
                9.6.7.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.    GlaxoSmithKline plc
                10.1.1.    Snapshot
                10.1.2.    Overview
                10.1.3.    Offerings
                10.1.4.    Financial Insight
                10.1.5.    Recent Developments
        10.2.    AstraZeneca
                10.2.1.    Snapshot
                10.2.2.    Overview
                10.2.3.    Offerings
                10.2.4.    Financial Insight
                10.2.5.    Recent Developments
        10.3.    Bristol-Myers Squibb Company
                10.3.1.    Snapshot
                10.3.2.    Overview
                10.3.3.    Offerings
                10.3.4.    Financial Insight
                10.3.5.    Recent Developments
        10.4.    Sun Pharmaceutical Industries Ltd.
                10.4.1.    Snapshot
                10.4.2.    Overview
                10.4.3.    Offerings
                10.4.4.    Financial Insight
                10.4.5.    Recent Developments
        10.5.    Eli Lilly and Company
                10.5.1.    Snapshot
                10.5.2.    Overview
                10.5.3.    Offerings
                10.5.4.    Financial Insight
                10.5.5.    Recent Developments
        10.6.    Novartis AG
                10.6.1.    Snapshot
                10.6.2.    Overview
                10.6.3.    Offerings
                10.6.4.    Financial Insight
                10.6.5.    Recent Developments
        10.7.    NATCO Pharma Limited
                10.7.1.    Snapshot
                10.7.2.    Overview
                10.7.3.    Offerings
                10.7.4.    Financial Insight
                10.7.5.    Recent Developments
        10.8.    Merck & Co.
                10.8.1.    Snapshot
                10.8.2.    Overview
                10.8.3.    Offerings
                10.8.4.    Financial Insight
                10.8.5.    Recent Developments
        10.9.    F. Hoffmann-La Roche Ltd, Inc.
                10.9.1.    Snapshot
                10.9.2.    Overview
                10.9.3.    Offerings
                10.9.4.    Financial Insight
                10.9.5.    Recent Developments
        10.10.    Bayer AG, Mylan N.V.
                10.10.1.    Snapshot
                10.10.2.    Overview
                10.10.3.    Offerings
                10.10.4.    Financial Insight
                10.10.5.    Recent Developments
        10.11.    Pfizer Inc. 
                10.11.1.    Snapshot
                10.11.2.    Overview
                10.11.3.    Offerings
                10.11.4.    Financial Insight
                10.11.5.    Recent Developments
        11.12.Sanofi
                11.12.1.    Snapshot
                11.12.2.    Overview
                11.12.3.    Offerings
                11.12.4.    Financial Insight
                11.12.5.    Recent Developments

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to availability of information in secondary domain.

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Flu Treatment Market Size, by Type, 2018 - 2023 (USD Billion)
Table 5 Global Flu Treatment Market Size, by Type, 2025 - 2030 (USD Billion)
Table 6 Global Flu Treatment Market Size, by Route of Administration, 2018 - 2023 (USD Billion)
Table 7 Global Flu Treatment Market Size, by Route of Administration, 2025 - 2030 (USD Billion)
Table 8 Global Flu Treatment Market Size, by Medication, 2018 - 2023 (USD Billion)
Table 9 Global Flu Treatment Market Size, by Medication, 2025 - 2030 (USD Billion)
Table 10 Global Flu Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 11 Global Flu Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 12 Global Flu Treatment Market Size, by Distribution Channel, 2018 - 2023 (USD Billion)
Table 13 Global Flu Treatment Market Size, by Distribution Channel, 2025 - 2030 (USD Billion)
Table 14 Global Flu Treatment Market Size, by Region, 2018 - 2023 (USD Billion)
Table 15 Global Flu Treatment Market Size, by Region, 2025 - 2030 (USD Billion)
Table 16 North America Flu Treatment Market Size, by Type, 2018 - 2023 (USD Billion)
Table 17 North America Flu Treatment Market Size, by Type, 2025 - 2030 (USD Billion)
Table 18 North America Flu Treatment Market Size, by Route of Administration, 2018 - 2023 (USD Billion)
Table 19 North America Flu Treatment Market Size, by Route of Administration, 2025 - 2030 (USD Billion)
Table 20 North America Flu Treatment Market Size, by Medication, 2018 - 2023 (USD Billion)
Table 21 North America Flu Treatment Market Size, by Medication, 2025 - 2030 (USD Billion)
Table 22 North America Flu Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 23 North America Flu Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 24 North America Flu Treatment Market Size, by Distribution Channel, 2018 - 2023 (USD Billion)
Table 25 North America Flu Treatment Market Size, by Distribution Channel, 2025 - 2030 (USD Billion)
Table 26 North America Flu Treatment Market Size, by Country, 2018 - 2023 (USD Billion)
Table 27 North America Flu Treatment Market Size, by Country, 2025 - 2030 (USD Billion)
Table 28 Europe Flu Treatment Market Size, by Type, 2018 - 2023 (USD Billion)
Table 29 Europe Flu Treatment Market Size, by Type, 2025 - 2030 (USD Billion)
Table 30 Europe Flu Treatment Market Size, by Route of Administration, 2018 - 2023 (USD Billion)
Table 31 Europe Flu Treatment Market Size, by Route of Administration, 2025 - 2030 (USD Billion)
Table 32 Europe Flu Treatment Market Size, by Medication, 2018 - 2023 (USD Billion)
Table 33 Europe Flu Treatment Market Size, by Medication, 2025 - 2030 (USD Billion)
Table 34 Europe Flu Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 35 Europe Flu Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 36 Europe Flu Treatment Market Size, by Distribution Channel, 2018 - 2023 (USD Billion)
Table 37 Europe Flu Treatment Market Size, by Distribution Channel, 2025 - 2030 (USD Billion)
Table 38 Europe Flu Treatment Market Size, by Country, 2018 - 2023 (USD Billion)
Table 39 Europe Flu Treatment Market Size, by Country, 2025 - 2030 (USD Billion)
Table 40 Asia-Pacific Flu Treatment Market Size, by Type, 2018 - 2023 (USD Billion)
Table 41 Asia-Pacific Flu Treatment Market Size, by Type, 2025 - 2030 (USD Billion)
Table 42 Asia-Pacific Flu Treatment Market Size, by Route of Administration, 2018 - 2023 (USD Billion)
Table 43 Asia-Pacific Flu Treatment Market Size, by Route of Administration, 2025 - 2030 (USD Billion)
Table 44 Asia-Pacific Flu Treatment Market Size, by Medication, 2018 - 2023 (USD Billion)
Table 45 Asia-Pacific Flu Treatment Market Size, by Medication, 2025 - 2030 (USD Billion)
Table 46 Asia-Pacific Flu Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 47 Asia-Pacific Flu Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 48 Asia-Pacific Flu Treatment Market Size, by Distribution Channel, 2018 - 2023 (USD Billion)
Table 49 Asia-Pacific Flu Treatment Market Size, by Distribution Channel, 2025 - 2030 (USD Billion)
Table 50 Asia-Pacific Flu Treatment Market Size, by Country, 2018 - 2023 (USD Billion)
Table 51 Asia-Pacific Flu Treatment Market Size, by Country, 2025 - 2030 (USD Billion)
Table 52 RoW Flu Treatment Market Size, by Type, 2018 - 2023 (USD Billion)
Table 53 RoW Flu Treatment Market Size, by Type, 2025 - 2030 (USD Billion)
Table 54 RoW Flu Treatment Market Size, by Route of Administration, 2018 - 2023 (USD Billion)
Table 55 RoW Flu Treatment Market Size, by Route of Administration, 2025 - 2030 (USD Billion)
Table 56 RoW Flu Treatment Market Size, by Medication, 2018 - 2023 (USD Billion)
Table 57 RoW Flu Treatment Market Size, by Medication, 2025 - 2030 (USD Billion)
Table 58 RoW Flu Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 59 RoW Flu Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 60 RoW Flu Treatment Market Size, by Distribution Channel, 2018 - 2023 (USD Billion)
Table 61 RoW Flu Treatment Market Size, by Distribution Channel, 2025 - 2030 (USD Billion)
Table 62 RoW Flu Treatment Market Size, by Country, 2018 - 2023 (USD Billion)
Table 63 RoW Flu Treatment Market Size, by Country, 2025 - 2030 (USD Billion)
Table 64 Snapshot – GlaxoSmithKline plc
Table 65 Snapshot – AstraZeneca
Table 66 Snapshot – Bristol-Myers Squibb Company
Table 67 Snapshot – Sun Pharmaceutical Industries Ltd.
Table 68 Snapshot – Eli Lilly and Company
Table 69 Snapshot – Novartis AG
Table 70 Snapshot – NATCO Pharma Limited 
Table 71 Snapshot – Merck & Co.
Table 72 Snapshot – F. Hoffmann-La Roche Ltd, Inc.
Table 73 Snapshot – Bayer AG
Table 74 Snapshot – Mylan N.V.
Table 75 Snapshot – Pfizer Inc.
Table 76 Snapshot – Sanofi

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Flu Treatment Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global Flu Treatment Market Highlight
Figure 12 Global Flu Treatment Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 13 Global Flu Treatment Market Size, by Route of Administration, 2018 - 2030 (USD Billion)
Figure 14 Global Flu Treatment Market Size, by Medication, 2018 - 2030 (USD Billion)
Figure 15 Global Flu Treatment Market Size, by End User, 2018 - 2030 (USD Billion)
Figure 16 Global Flu Treatment Market Size, by Distribution Channel, 2018 - 2030 (USD Billion)
Figure 17 Global Flu Treatment Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 18 North America Flu Treatment Market Highlight
Figure 19 North America Flu Treatment Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 20 North America Flu Treatment Market Size, by Route of Administration, 2018 - 2030 (USD Billion)
Figure 21 North America Flu Treatment Market Size, by Medication, 2018 - 2030 (USD Billion)
Figure 22 North America Flu Treatment Market Size, by End User, 2018 - 2030 (USD Billion)
Figure 23 North America Flu Treatment Market Size, by Distribution Channel, 2018 - 2030 (USD Billion)
Figure 24 North America Flu Treatment Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 25 Europe Flu Treatment Market Highlight
Figure 26 Europe Flu Treatment Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 27 Europe Flu Treatment Market Size, by Route of Administration, 2018 - 2030 (USD Billion)
Figure 28 Europe Flu Treatment Market Size, by Medication, 2018 - 2030 (USD Billion)
Figure 29 Europe Flu Treatment Market Size, by End User, 2018 - 2030 (USD Billion)
Figure 30 Europe Flu Treatment Market Size, by Distribution Channel, 2018 - 2030 (USD Billion)
Figure 31 Europe Flu Treatment Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 32 Asia-Pacific Flu Treatment Market Highlight
Figure 33 Asia-Pacific Flu Treatment Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 34 Asia-Pacific Flu Treatment Market Size, by Route of Administration, 2018 - 2030 (USD Billion)
Figure 35 Asia-Pacific Flu Treatment Market Size, by Medication, 2018 - 2030 (USD Billion)
Figure 36 Asia-Pacific Flu Treatment Market Size, by End User, 2018 - 2030 (USD Billion)
Figure 37 Asia-Pacific Flu Treatment Market Size, by Distribution Channel, 2018 - 2030 (USD Billion)
Figure 38 Asia-Pacific Flu Treatment Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 39 RoW Flu Treatment Market Highlight
Figure 40 RoW Flu Treatment Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 41 RoW Flu Treatment Market Size, by Route of Administration, 2018 - 2030 (USD Billion)
Figure 42 RoW Flu Treatment Market Size, by Medication, 2018 - 2030 (USD Billion)
Figure 43 RoW Flu Treatment Market Size, by End User, 2018 - 2030 (USD Billion)
Figure 44 RoW Flu Treatment Market Size, by Distribution Channel, 2018 - 2030 (USD Billion)
Figure 45 RoW Flu Treatment Market Size, by Country, 2018 - 2030 (USD Billion)